Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal, forming crypto-focused Hyperliquid Strategies ...

Atlantic Theater Company has revealed its Judith Champion Launch Commissioning Program writers for 2025. Learn more about the ...

HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token ...

You’d think that in a sleepy town like Camarillo, where the hottest debates—usually in the local Facebook mom group—revolve ...

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

At the closing of the transaction, the newly created combined entity will be named Hyperliquid Strategies Inc., which is ...

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasuryPRINCETON, N.J., July 14, 2025 ( ...

We are here to take a look at the NFL's best QB-RB-WR/TE trios, also known as their "triplets," in reference to the famed ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...